Clinical Characteristics and Prognostic Value of Persistent Airflow Limitation in the NOVELTY Cohort

Clinical Characteristics and Prognostic Value of Persistent Airflow Limitation in the NOVELTY Cohort

On September 17, the New Zealand Medical Institute published a paper by Richard Beasley in the Annals of the American Thoracic Society titled “Prevalence and Clinical Characteristics of Persistent Airflow Limitation in the NOVELTY Cohort“. This large-scale study, based on the NOVELTY observational longitudinal cohort, explores the prevalence, clinical characteristics, and prognostic significance of Persistent … Read more

Learning BLE from Scratch: Controlling Devices

Learning BLE from Scratch: Controlling Devices

Previously, we introduced the process of discovering services and characteristics. Today, let’s take a look at what happens next.In the software, we click to control the light to turn it on and off. The data sent by the host is as follows:Captured dataOperation codeOperation code 0x12: write request.Write requestWriting the value 0x0001 to the attribute … Read more

Learning BLE from Scratch: Discovering Services and Characteristics

Learning BLE from Scratch: Discovering Services and Characteristics

Through previous studies, we learned that BLE devices act as servers, storing some data, while clients achieve corresponding functions by reading, writing, and configuring this data. Previously, we learned about broadcasting and connections; today, let’s take a look at what happens after a connection is established.Discovery of Services and CharacteristicsAfter a device establishes a connection, … Read more

Clinical Characteristics of Anti-LGI1 Antibody Encephalitis and Anti-GABA-B Receptor Encephalitis

Clinical Characteristics of Anti-LGI1 Antibody Encephalitis and Anti-GABA-B Receptor Encephalitis

Autoimmune encephalitis (AE) refers to encephalitis mediated by autoimmune mechanisms. Those associated with tumors are termed paraneoplastic AE, while those without tumors are classified based on the presence of autoantibodies against neuronal cell surface or synaptic proteins. Currently, clinically detectable antibodies include N-methyl-D-aspartate receptor (NMDAR) antibodies, anti-gamma-aminobutyric acid-B receptor (GABABR) antibodies, anti-leucine-rich glioma inactivated 1 … Read more